Condition

Obesity or Overweight clinical trials and research

• 11Clinical trials
• 33Countries

Newest Obesity or Overweight clinical trials

All recruiting trials (11)

• Petrelintide for weight management in adults with overweight or obesity

  This study tests whether petrelintide helps people with overweight or obesity lose weight when combined with a reduced-calorie diet and more exercise, compared with a placebo.

  Recruiting at 8 sites Phase 3 Hoffmann-La Roche · Anniston, Alabama and 7 other locations · NCT07843498

• Petrelintide for weight management in adults with overweight/obesity and type 2 diabetes

  This study tests whether petrelintide, added to a reduced-calorie diet and more physical activity, helps people with overweight or obesity and type 2 diabetes lose weight more effectively than a placebo.

  Recruiting at 2 sites Phase 3 Hoffmann-La Roche · Los Angeles, California and 1 other locations · NCT07843485

• Petrelintide for weight loss in people with overweight/obesity and heart disease

  This study tests whether petrelintide helps people with overweight or obesity and cardiovascular disease lose weight when added to a reduced-calorie diet and more physical activity, compared with a placebo.

  Recruiting at 3 sites Phase 3 Hoffmann-La Roche · Anniston, Alabama and 2 other locations · NCT07843472

• AZD6234: a new weekly shot to help adults lose weight

  This Phase 3 trial tests whether AZD6234 helps adults with obesity or overweight and weight-related health issues lose weight compared to placebo.

  Recruiting at 76 sites Phase 3 AstraZeneca · Dothan, Alabama and 219 other locations · NCT07784725

• AZD6234: a new option for adults with type 2 diabetes and excess weight

  A phase 3 trial tests whether AZD6234 helps adults with type 2 diabetes and overweight or obesity more than placebo over about 68 weeks.

  Recruiting at 58 sites Phase 3 AstraZeneca · Fairhope, Alabama and 229 other locations · NCT07784270

• AZD6234 added to current diabetes therapy to help with weight loss in adults who are overweight or have obesity

  This study tests whether AZD6234, when added to a person’s current incretin-based weight management therapy, can help adults with obesity or overweight lose more weight than a placebo over about 68 weeks.

  Recruiting at 56 sites Phase 3 AstraZeneca · Escondido, California and 95 other locations · NCT07776509

• Switching GLP-1 RA to Maridebart Cafraglutide in Adults with Obesity or Overweight

  This study tests whether switching from a GLP-1 receptor agonist to maridebart cafraglutide is safe and tolerable for adults who are overweight or obese.

  Recruiting at 56 sites Phase 3 Amgen · Pelham, Alabama and 56 other locations · NCT07575399

• Enicepatide for weight management in people with overweight or obesity and type 2 diabetes

  This trial tests whether enicepatide helps adults with overweight or obesity and type 2 diabetes lose weight compared with a placebo.

  Recruiting at 222 sites Phase 3 Hoffmann-La Roche · Guntersville, Alabama and 221 other locations · NCT07351058

• Enicepatide for weight loss in adults with overweight or obesity without Type 2 diabetes

  This study will test whether different doses of enicepatide help adults with overweight or obesity who do not have Type 2 diabetes lose weight compared with placebo and are safe.

  Recruiting at 209 sites Phase 3 Hoffmann-La Roche · Anniston, Alabama and 208 other locations · NCT07351045

• Mirikizumab with or without tirzepatide for adults with moderately to severely active Crohn's disease who are overweight or have obesity

  This trial tests whether adding tirzepatide to mirikizumab helps adults with moderately to severely active Crohn's disease who are overweight or have obesity.

  Recruiting at 174 sites Phase 3 Eli Lilly and Company · Dothan, Alabama and 182 other locations · NCT06937099

• Mirikizumab given at the same time as tirzepatide for adults with moderate-to-severe ulcerative colitis who are overweight or have obesity

  This will test whether giving mirikizumab together with tirzepatide helps adults with moderate-to-severe ulcerative colitis who are overweight or obese reduce UC symptoms and lose at least 10% of their body weight.

  Recruiting at 179 sites Phase 3 Eli Lilly and Company · Dothan, Alabama and 185 other locations · NCT06937086

Related topics

Quick answers

How many Obesity or Overweight clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 33 countries. The most sites are in United States (11 trials), Canada (7 trials), Brazil (6 trials), Germany (6 trials), Poland (6 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 11. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →